Off-Label Promotion — The Elephant in the Room Understanding the Regulatory and Product Liability Concerns of FDA/DOJ Enforcement

$327.00
Quantity Discounts
1 - 9999
$327.00
1 - 9999
$527.00
Back By Popular Demand!
An FDAnews
Webinar Rebroadcast

Our buyers have spoken – and we’re responding. By popular demand, FDAnews is rebroadcasting this best-selling event from earlier in 2011.

It’s your best opportunity – and last chance – to attend one of our highest-rated events this year.

More than 100 attended this invaluable webinar the first time around. Here’s what one of our satisfied registrants had to say:

“The speaker was very knowledgeable.”
            Carrie Osing, RA Manager, Bisco

Wrap up your 2011 on a high note … with this special one-time-only encore presentation.


Off-label promotion is illegal — that’s a well known fact.

What you might not know is that your firm could face significant product liability (and other) lawsuits because of off-label violations.

Here’s how to educate your staff about the regulatory, legal and product liability pitfalls of off-label promotion.

If your company loses a product liability lawsuit, it could cost thousands (even millions) of dollars.

It could also cost you your job.

This is not mere scare talk. The Justice Department has been working on 200+ investigations of off-label violations involving some 500 products. And the FDA’s Office of Criminal Investigations (OCI) maintains a special prosecutions staff to look into illegal off-label promotion of approved devices and drugs.

Yet far too many drug and device company employees simply don’t know the rules. Training is spotty, sometimes nonexistent.

Here’s how to learn what you need to know.

Mark your calendar for Wednesday, Dec. 7, 2011, when a recognized authority on product liability issues shows how to protect your company — and yourself — from fines, lawsuits, even prison time.

Using case studies as illustrations, attorney Sara Dyson will discuss the issues concerning off-label promotion. By the end of this intensive 90-minute webinar, you’ll have the toolkit you need to head off violations in your workplace.

Here are just a few things you’ll discover:

  • Off-label use and promotion — what it is, how to avoid it
  • Traditional and nontraditional causes of action related to off-label promotion
  • 2 major defenses against liability
  • The FDA’s Good Reprint Practices guidelines on off-label product uses
  • Penalties for off-label violations
  • Illegal promotion vs. “scientific information exchange” — what’s legal, what’s not
  • High-profile cases in which drug/device firms have been held liable (or not)
  • The “Practice of Medicine” exemption — its strengths and weaknesses
  • Best practices for managing off-label promotion risks
  • Tips on creating an effective off-label compliance program
  • And much more

Off-Label Promotion is convenient to attend. All that’s required is that you be in front of a screen at the appointed time, whether you work at the office or telecommute from your office at home.

Key people throughout your company will benefit from taking part in this event. Best of all, everyone can do so at a cost that won’t break your budget. You pay one single low registration fee per facility, regardless of how many participate. So spread the word.

With both the Justice Department and the FDA snooping around, it simply doesn’t make sense to risk an off-label violation. Protect your company — and yourself. Sign up today for this timely learning event.

Top management, compliance officials, regulatory and legal staff are certain to want to sign up, as well as advertising, marketing, sales and more. Here’s a list of suggested attendees to choose from –

  • Compliance Officers
  • Executive Management
  • General/Corporate Counsel
  • Regulatory/Legislative Affairs Professionals
  • Risk Management Specialist
  • Sales and Marketing Personnel
  • Training Personnel
  • Medical Science Liaisons
  • Outside Attorneys

Sara Dyson Esq. is assistant VP for loss control of Medmarc Insurance Group, a provider of product liability insurance to the life sciences industry. She performs risk evaluations of life sciences companies and recommends tailored risk management solutions. She is responsible for developing educational resources in product liability, risk management and related specialties, including FDA compliance and regulation, post-market surveillance, product safety and recalls. Ms. Dyson earned her law degree from the University of Wisconsin and is a member of the Wisconsin and Virginia Bars.

Register now!

Date: Wednesday, Dec. 7, 2011
Location: Your office or conference room (no need to travel!)
Time: 11:00 a.m. – 12:30 p.m. EST
  10:00 a.m. – 11:30 a.m. CST
  9:00 a.m. – 10:30 a.m. MST
  8:00 a.m. – 9:30 a.m. PST
  4:00 p.m. – 5:30 p.m. GMT

Gather your team for maximum benefit! Your investment is for one dial-in.

Interested in registering multiple sites?

Significant tuition discounts are available for three or more sites from
the same company. You must register at the same time and
provide a single payment to take advantage of the discount. Register below
by clicking on add to cart and then change your quantity in the shopping cart.
The discount will be calculated automatically.

3-4 sites – 10%
7-9 sites – 20%
5-6 sites – 15%
10+ sites – 25%

Call (888) 838-5578 in the U.S. or +1 (703) 538-7600 globally
with any questions.

We accept American Express, Visa and MasterCard. Make checks payable to FDAnews.

Or, register by phone: toll free (888) 838-5578 (inside the U.S.) or +1 (703) 538-7600

Cancellations/Substitutions
Registrations may not be cancelled. Please contact customer service to make any substitutions.

Interested in Becoming a Speaker?
We're always looking for industry leaders eager to share their expertise at an FDAnews audioconference, webinar or physical conference. Our seasoned speaker community includes executives in the pharmaceutical, medical device and clinical trial industries, regulatory affairs, quality control, compliance, healthcare and academia, as well as several former — and current — top FDA officials. Click here to complete our speaker opportunity form and have a representative contact you about future opportunities.